Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: EKF, Petershill and Dunelm chairs buy shares

Tue, 03rd May 2022 14:23

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay maker - Non-Executive Chair Christopher Mills buys 1.3 million shares at 35p, worth GBP446,250, on Thursday last week. Now has 132.2 million shares, a 29% stake.

----------

Petershill Partners PLC - investment vehicle managed by Goldman Sachs Asset Management that invests in alternative asset managers - Chair Naguib Kheraj buys 125,000 shares at GBP2.55, worth GBP319,375, on Tuesday.

----------

Dunelm Group PLC - Leicester, England-based home furnishings retailer - Chair Andy Harrison buys 10,117 shares at 981 pence, worth GBP99,248, on Friday last week. Now has 454,811 shares, a 0.2% stake.

----------

Abcam PLC - Cambridge, England-based life science research tools - Non-Executive Director Sally Crawford buys 15,000 American depositary shares at average USD15.41, worth USD231,076, on Thursday and Friday. Each ADS is represents one ordinary share.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
20 Apr 2020 10:02

Abcam warns on revenues as Covid-19 hits markets

(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.

Read more
20 Apr 2020 09:41

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

Read more
14 Apr 2020 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
9 Apr 2020 18:07

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
10 Mar 2020 09:38

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

Read more
9 Mar 2020 15:48

Abcam 'uncertain' about coronavirus impact as China returns to work

(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results on Monday, to ?138.2m.

Read more
9 Mar 2020 10:29

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

Read more
9 Mar 2020 09:55

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

Read more
4 Mar 2020 10:26

Abcam acquires Marker Gene Technologies

(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.

Read more
4 Mar 2020 10:13

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Read more
2 Mar 2020 15:56

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
30 Jan 2020 10:51

Abcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio

Abcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio

Read more
28 Jan 2020 18:46

DIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale

DIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.